Soft Tissue Sarcoma
Conditions
Interventions
Long-term radiotherapy group:Long term radiotherapy with CTVtb 60Gy/25F (2.4Gy/1F) and CTV 50Gy/25F (2Gy/1F) (two CTVs are synchronously integrated and pushed, completed within 5 weeks).
Short-term radiotherapy group:Short term radiotherapy with 51.6 Gy/15F (3.44 Gy/1F) and CTV at 43.5 Gy/15F (2.9 Gy/1F) (two CTVs integrated and pushed simultaneously, completed within 3 weeks).
Sponsors
The First Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The patient's pathology confirmed a soft tissue sarcoma, and the primary lesion has been resected with R0 margin. 2. Age >= 18 years old. 3. Karnofsky Performance Status (KPS) >= 60. 4. No distant metastasis has occurred. 5. Has signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pathological types include embryonal rhabdomyosarcoma, extraosseous Ewing's sarcoma and aggressive fibromatosis (desmoid tumor). 2. Patients who have participated in other clinical trials and have not yet terminated those trials. 3. The tumor bed area of the primary tumor has previously received radiotherapy. 4. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse-Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Metastasis-Free Survival;Disease-Free Survival;Overall Suvival; | — |
Countries
China
Contacts
Public ContactShen Guoping
The First Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed